Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • About
  • Communities & Collections
  • Advanced Search
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Medicine
  3. Department of Medicine
  4. Department of Medicine (up to 2019)
  5. Conformational activation of ADAMTS13
 
  • Details
Conformational activation of ADAMTS13
File(s)
PNAS_108_28_2011.pdf (620.97 KB)
Accepted version
Author(s)
South, Kieron
Luken, Brenda M
Crawley, James TB
Phillips, Rebecca
Thomas, Mari
more
Type
Journal Article
Abstract
A disintegrin and metalloprotease with thrombospondin motifs 13 (ADAMTS13) is a metalloprotease that regulates von Willebrand factor (VWF) function. ADAMTS13-mediated proteolysis is determined by conformational changes in VWF, but also may depend on its own conformational activation. Kinetic analysis of WT ADAMTS13 revealed ∼2.5-fold reduced activity compared with ADAMTS13 lacking its C-terminal tail (MDTCS) or its CUB1-2 domains (WTΔCUB1-2), suggesting that the CUB domains naturally limit ADAMTS13 function. Consistent with this suggestion, WT ADAMTS13 activity was enhanced ∼2.5-fold by preincubation with either an anti-CUB mAb (20E9) or VWF D4CK (the natural binding partner for the CUB domains). Furthermore, the isolated CUB1-2 domains not only bound MDTCS, but also inhibited activity by up to 2.5-fold. Interestingly, a gain-of-function (GoF) ADAMTS13 spacer domain variant (R568K/F592Y/R660K/Y661F/Y665F) was ∼2.5-fold more active than WT ADAMTS13, but could not be further activated by 20E9 mAb or VWF D4CK and was unable to bind or to be inhibited by the CUB1-2 domains, suggesting that the inhibitory effects of the CUB domains involve an interaction with the spacer domain that is disrupted in GoF ADAMTS13. Electron microscopy demonstrated a “closed” conformation of WT ADAMTS13 and suggested a more “open” conformation for GoF ADAMTS13. The cryptic spacer domain epitope revealed by conformational unfolding also represents the core antigenic target for autoantibodies in thrombotic thrombocytopenic purpura. We propose that ADAMTS13 circulates in a closed conformation, which is maintained by a CUB–spacer domain binding interaction. ADAMTS13 becomes conformationally activated on demand through interaction of its C-terminal CUB domains with VWF, making it susceptible to immune recognition.
Date Issued
2014-12-30
Date Acceptance
2014-12-01
Citation
Proceedings of the National Academy of Sciences of the United States of America, 2014, 111 (52), pp.18578-18583
URI
http://hdl.handle.net/10044/1/20073
URL
https://www.pnas.org/content/111/52/18578
DOI
https://www.dx.doi.org/10.1073/pnas.1411979112
ISSN
0027-8424
Publisher
National Academy of Sciences
Start Page
18578
End Page
18583
Journal / Book Title
Proceedings of the National Academy of Sciences of the United States of America
Volume
111
Issue
52
Copyright Statement
© 2014 National Academy of Sciences.
License URL
http://www.rioxx.net/licenses/all-rights-reserved
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000347444400049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Multidisciplinary Sciences
Science & Technology - Other Topics
ADAMTS13
VWF
TTP
autoantibodies
VON-WILLEBRAND-FACTOR
THROMBOTIC THROMBOCYTOPENIC PURPURA
FACTOR A2 DOMAIN
VONWILLEBRAND-FACTOR
SCISSILE BOND
BINDING-SITE
VICINAL CYSTEINES
SPACER DOMAIN
HUMAN-PLASMA
FACTOR-VIII
Publication Status
Published
Date Publish Online
2014-12-15
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback